Zapalowski Carol MD - CO Denver, Denver 80209

Zapalowski Carol MD entered the industry of Internal Medicine Doctors in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.

To acquire more information, please contact Carol Zapalowski by calling (303) 394-0031 during business hours. You can also write to the business’ Single Location at 3865 East Cherry Creek North Drive # 322, Denver, Colorado CO 80209. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Zapalowski Carol MD
Representative: Carol Zapalowski
Place of Business: 3865 East Cherry Creek North Drive # 322, Denver, CO 80209
Contact Number: (303) 394-0031
Type of Service: Internal Medicine Doctors
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2010
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Zapalowski Carol MD is a company operating from Denver, Colorado providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 6211110 as Internal Medicine Doctors.

With a current employee count of 1 to 4, Zapalowski Carol MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Carol Zapalowski at (303) 394-0031 for related queries, or to locate its Single Location using the coordinates 39.707646,-104.94233.

The Single Location can also be found at the street address 3865 East Cherry Creek North Drive # 322 in Denver, Colorado 80209 and can be engaged online through the company website at , the company Twitter , and Facebook page .